Skip to main content
Loading
loadingbar
Loading, Please wait..!!

Senior Clinical Marketing Director

  • Senior Clinical Marketing Director job type Posted on: Nov 03, 2026
  • Senior Clinical Marketing Director experience level Connecticut Innovations
  • Senior Clinical Marketing Director employment type Mundelein, Illinois
  • Senior Clinical Marketing Director employment type Onsite
  • Senior Clinical Marketing Director salary Full-time

Point Apply Here APPLY LATER

Curious about compensation?

Explore the historical salary trends, average pay, and estimated compensation for Senior Clinical Marketing Director roles in Illinois.

View Salary Guide →

Job Title :

Senior Clinical Marketing Director

Job Type :

Full-Time

Job Location :

Mundelein Illinois United States

Remote :

No

Jobcon Logo Job Description :

Job Description

Are you ready to join Connecticut Innovation’s vibrant community of innovators? Connecticut Innovations (“CI”) is Connecticut’s strategic venture capital arm, and we are passionate about serving our portfolio of 220+ companies across various industries, with strengths in life sciences, technology, and climate tech.

\n


\n

Come join CI Portfolio Company, UltraSight- AI Powered Cardiac Ultrasound as their newest Senior Clinical Marketing Director!

\n


\n

ABOUT THE ROLE

\n

UltraSight is an AI-powered cardiac workflow company advancing access to high quality cardiac ultrasound. The UltraSight EchoSystem brings together structured training, real-time AI guidance and interpretation, and advanced analytics, so clinical providers beyond the cardiac sonographer can perform focused echocardiography at the bedside under qualified physician oversight. The result for health systems is more echo capacity, shorter backlogs, and faster cardiac insight across the ICU, ER and inpatient settings.

\n


\n

The company is FDA 510(k) cleared, has the EchoSystem deployed across more than 10 commercial sites spanning intensive care settings, and recently raised $24 million in Series B2 financing to scale its U.S. commercial expansion and build new workflows for the ICU and circulatory support. Its clinical evidence base is unusually deep for its stage, including twelve studies presented across ACC, ASE and ESC in 2026, a JAMA Cardiology publication, and late breaking PVAD IQ data at THT 2026.

\n


\n

UltraSight is moving from proving the technology to winning health system adoption. The evidence is there. The commercial team is being built. What the company needs is a leader who can turn clinical evidence into a clinical story that physicians, nurse leaders, echo lab directors and hospital executives each find credible, and who can carry that story from the first customer insight through to measured adoption at the bedside.

\n


\n

This is a specific skill set, distinct from public relations, communications and collateral production, which UltraSight already covers through external partners. This role owns the clinical substance behind the message: what the evidence says, who needs to hear it, how clinicians are trained and enabled to use it, and how that drives utilization. The right person starts as a hands on builder and grows into the clinical voice of the commercial organization as UltraSight scales.

\n


\n

Clinical Strategy and Evidence

\n
    \n
  • Define the clinical value proposition and positioning by care setting and use case (ER, ICU, CCU, inpatient, out of hospital), anchored in workflow, throughput and capacity outcomes
  • \n
  • Run the voice of customer engine with intensivists, cardiologists, echo lab leaders, sonographers, nursing leadership and hospital administrators, and translate what is learned into product roadmap and commercial priorities
  • \n
  • Partner with clinical, regulatory and R&D on evidence strategy: publication planning, congress presentations, and investigator led research, so evidence maps directly to the questions buyers and clinicians ask
  • \n
  • Build and manage KOL, advisory board and investigator relationships that give UltraSight lasting clinical credibility
  • \n
  • Segment and prioritize indications, care settings and customer types, and contribute clinical input to launch planning for new workflows
  • \n
  • Track the competitive landscape, including other AI guidance and point of care ultrasound solutions, and sharpen clinical differentiation
  • \n
\n


\n

Clinical Adoption and Enablement

\n
    \n
  • Build the clinical messaging and claims framework, aligned to cleared labeling and reviewed with regulatory and quality, that sales and clinical account teams use in every customer conversation
  • \n
  • Develop clinical education and training content that builds user competency and confidence, in partnership with the clinical team
  • \n
  • Equip the field with evidence based selling tools: clinical case studies, health system value stories, objection handling, and utilization playbooks
  • \n
  • Build peer to peer programs, customer champions and speaker programs, and own UltraSight's clinical presence at key congresses
  • \n
  • Define and track clinical adoption and utilization metrics with commercial leadership, and feed what the field learns back upstream
  • \n
  • Brief and direct external PR, communications, content and web partners so that everything they produce is clinically accurate and consistent, without owning their execution
  • \n
\n


\n

Cross-Functional Leadership

\n
    \n
  • Partner closely with the CCO, commercial development, market access, commercial operations, clinical and regulatory leaders to keep evidence, access strategy, enablement and field execution aligned
  • \n
  • Build the clinical marketing function from the ground up, starting as an individual contributor with the option to grow a team as the company scales
  • \n
\n


\n

QUALIFICATIONS

\n

This role is built for a clinically fluent marketer who is equally comfortable at the bedside, in an advisory board meeting, and in a hospital executive's office. You take clinical evidence seriously and know how to make it useful to a busy clinician. You do not wait to be handed a brief: you find the question the customer is really asking and build the answer before the field needs it. You are energized by building something that does not exist yet, at a company where the evidence is strong and the market is open.

\n


\n

Required

\n


\n
    \n
  • Clinical marketing ownership in medical device, digital health or health technology: not promotional marketing alone, but the clinical strategy and evidence narrative behind it
  • \n
  • Proven ability to translate clinical data and publications into positioning, messaging and sales tools that move health system decisions
  • \n
  • Credibility with physicians and clinical leaders, including KOL development, advisory boards and congress engagement
  • \n
  • Experience operating in a regulated environment, including promotional review and keeping claims within cleared labeling
  • \n
  • Hands on startup or growth stage builder who has created a function, not just maintained one
  • \n
\n


\n

Preferred

\n


\n
    \n
  • Background in cardiac imaging, echocardiography, point of care ultrasound, critical care or cardiovascular devices
  • \n
  • Experience marketing AI enabled software or software as a medical device into hospitals and health systems
  • \n
  • Clinical training or credentials (for example RN, RDCS, PA or MD), or deep working fluency with clinical teams
  • \n
  • Experience creating or expanding a category and taking a new workflow or standard of care to adoption
  • \n
  • Comfort building the health system value story: workflow, capacity, throughput and economics
  • \n
  • Experience with ICU, ER, structural heart or circulatory support customers
  • \n
\n


\n

WORKING AT ULTRASIGHT

\n


\n
    \n
  • Category defining technology: AI guided cardiac ultrasound that extends echo capacity beyond the cardiac sonographer
  • \n
  • Strong clinical validation: peer reviewed evidence across multiple publications and major cardiology congresses
  • \n
  • Funded for growth: $24 million Series B2 raised in September 2026 to scale U.S. commercial expansion
  • \n
  • Equity participation in a high growth company
  • \n
  • Direct access to the Chief Commercial Officer and the executive team, with room to build the function your way
  • \n
\n


\n

Compensation: Competitive base + equity; commensurate with experience.

\n


\n

EQUAL OPPORTUNITY EMPLOYER

\n


\n

Connecticut Innovations and its portfolio companies are an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. We have strict wage minimums, generous benefits, and personal leave policies. Our goal is to provide safe, rewarding, and empowering work environments for all who interact with our company and/or portfolio companies.

Jobcon Logo Position Details

Posted:

Nov 03, 2026

Reference Number:

598d39902a4651e1

Employment:

Full-time

City:

Mundelein

Job Origin:

ziprecruiter

Share this job:

  • linkedin

Jobcon Logo
A job sourcing event
In Dallas Fort Worth
Aug 19, 2017 9am-6pm
All job seekers welcome!

Senior Clinical Marketing Director    Apply

Click on the below icons to share this job to Linkedin, Twitter!

Job Description

Are you ready to join Connecticut Innovation’s vibrant community of innovators? Connecticut Innovations (“CI”) is Connecticut’s strategic venture capital arm, and we are passionate about serving our portfolio of 220+ companies across various industries, with strengths in life sciences, technology, and climate tech.

\n


\n

Come join CI Portfolio Company, UltraSight- AI Powered Cardiac Ultrasound as their newest Senior Clinical Marketing Director!

\n


\n

ABOUT THE ROLE

\n

UltraSight is an AI-powered cardiac workflow company advancing access to high quality cardiac ultrasound. The UltraSight EchoSystem brings together structured training, real-time AI guidance and interpretation, and advanced analytics, so clinical providers beyond the cardiac sonographer can perform focused echocardiography at the bedside under qualified physician oversight. The result for health systems is more echo capacity, shorter backlogs, and faster cardiac insight across the ICU, ER and inpatient settings.

\n


\n

The company is FDA 510(k) cleared, has the EchoSystem deployed across more than 10 commercial sites spanning intensive care settings, and recently raised $24 million in Series B2 financing to scale its U.S. commercial expansion and build new workflows for the ICU and circulatory support. Its clinical evidence base is unusually deep for its stage, including twelve studies presented across ACC, ASE and ESC in 2026, a JAMA Cardiology publication, and late breaking PVAD IQ data at THT 2026.

\n


\n

UltraSight is moving from proving the technology to winning health system adoption. The evidence is there. The commercial team is being built. What the company needs is a leader who can turn clinical evidence into a clinical story that physicians, nurse leaders, echo lab directors and hospital executives each find credible, and who can carry that story from the first customer insight through to measured adoption at the bedside.

\n


\n

This is a specific skill set, distinct from public relations, communications and collateral production, which UltraSight already covers through external partners. This role owns the clinical substance behind the message: what the evidence says, who needs to hear it, how clinicians are trained and enabled to use it, and how that drives utilization. The right person starts as a hands on builder and grows into the clinical voice of the commercial organization as UltraSight scales.

\n


\n

Clinical Strategy and Evidence

\n
    \n
  • Define the clinical value proposition and positioning by care setting and use case (ER, ICU, CCU, inpatient, out of hospital), anchored in workflow, throughput and capacity outcomes
  • \n
  • Run the voice of customer engine with intensivists, cardiologists, echo lab leaders, sonographers, nursing leadership and hospital administrators, and translate what is learned into product roadmap and commercial priorities
  • \n
  • Partner with clinical, regulatory and R&D on evidence strategy: publication planning, congress presentations, and investigator led research, so evidence maps directly to the questions buyers and clinicians ask
  • \n
  • Build and manage KOL, advisory board and investigator relationships that give UltraSight lasting clinical credibility
  • \n
  • Segment and prioritize indications, care settings and customer types, and contribute clinical input to launch planning for new workflows
  • \n
  • Track the competitive landscape, including other AI guidance and point of care ultrasound solutions, and sharpen clinical differentiation
  • \n
\n


\n

Clinical Adoption and Enablement

\n
    \n
  • Build the clinical messaging and claims framework, aligned to cleared labeling and reviewed with regulatory and quality, that sales and clinical account teams use in every customer conversation
  • \n
  • Develop clinical education and training content that builds user competency and confidence, in partnership with the clinical team
  • \n
  • Equip the field with evidence based selling tools: clinical case studies, health system value stories, objection handling, and utilization playbooks
  • \n
  • Build peer to peer programs, customer champions and speaker programs, and own UltraSight's clinical presence at key congresses
  • \n
  • Define and track clinical adoption and utilization metrics with commercial leadership, and feed what the field learns back upstream
  • \n
  • Brief and direct external PR, communications, content and web partners so that everything they produce is clinically accurate and consistent, without owning their execution
  • \n
\n


\n

Cross-Functional Leadership

\n
    \n
  • Partner closely with the CCO, commercial development, market access, commercial operations, clinical and regulatory leaders to keep evidence, access strategy, enablement and field execution aligned
  • \n
  • Build the clinical marketing function from the ground up, starting as an individual contributor with the option to grow a team as the company scales
  • \n
\n


\n

QUALIFICATIONS

\n

This role is built for a clinically fluent marketer who is equally comfortable at the bedside, in an advisory board meeting, and in a hospital executive's office. You take clinical evidence seriously and know how to make it useful to a busy clinician. You do not wait to be handed a brief: you find the question the customer is really asking and build the answer before the field needs it. You are energized by building something that does not exist yet, at a company where the evidence is strong and the market is open.

\n


\n

Required

\n


\n
    \n
  • Clinical marketing ownership in medical device, digital health or health technology: not promotional marketing alone, but the clinical strategy and evidence narrative behind it
  • \n
  • Proven ability to translate clinical data and publications into positioning, messaging and sales tools that move health system decisions
  • \n
  • Credibility with physicians and clinical leaders, including KOL development, advisory boards and congress engagement
  • \n
  • Experience operating in a regulated environment, including promotional review and keeping claims within cleared labeling
  • \n
  • Hands on startup or growth stage builder who has created a function, not just maintained one
  • \n
\n


\n

Preferred

\n


\n
    \n
  • Background in cardiac imaging, echocardiography, point of care ultrasound, critical care or cardiovascular devices
  • \n
  • Experience marketing AI enabled software or software as a medical device into hospitals and health systems
  • \n
  • Clinical training or credentials (for example RN, RDCS, PA or MD), or deep working fluency with clinical teams
  • \n
  • Experience creating or expanding a category and taking a new workflow or standard of care to adoption
  • \n
  • Comfort building the health system value story: workflow, capacity, throughput and economics
  • \n
  • Experience with ICU, ER, structural heart or circulatory support customers
  • \n
\n


\n

WORKING AT ULTRASIGHT

\n


\n
    \n
  • Category defining technology: AI guided cardiac ultrasound that extends echo capacity beyond the cardiac sonographer
  • \n
  • Strong clinical validation: peer reviewed evidence across multiple publications and major cardiology congresses
  • \n
  • Funded for growth: $24 million Series B2 raised in September 2026 to scale U.S. commercial expansion
  • \n
  • Equity participation in a high growth company
  • \n
  • Direct access to the Chief Commercial Officer and the executive team, with room to build the function your way
  • \n
\n


\n

Compensation: Competitive base + equity; commensurate with experience.

\n


\n

EQUAL OPPORTUNITY EMPLOYER

\n


\n

Connecticut Innovations and its portfolio companies are an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. We have strict wage minimums, generous benefits, and personal leave policies. Our goal is to provide safe, rewarding, and empowering work environments for all who interact with our company and/or portfolio companies.

Loading
Please wait..!!